Table 5

- Site/type of synchronous/metachronous tumors (n=33).

Site/Typen (%)
Thyroid8 (1.9)
Breast4 (1.0)
Hematological3 (0.7)
Endometrial3 (0.7)
Stomach2 (0.5)
Hepatocellular carcinoma1 (0.2)
Pituitary adenoma1 (0.2)
Meningioma1 (0.2)
Appendicular adenocarcinoma1 (0.2)
Colorectal1 (0.2)
Renal cell carcinoma1 (0.2)
Duodenal/bowel1 (0.2)
Lung1 (0.2)
Pleomorphic adenoma1 (0.2)
Parathyroid adenoma1 (0.2)
Osteosarcoma1 (0.2)
Ewing sarcoma1 (0.2)
Ovarian cancer1 (0.2)